Evidence map›Paper›PMID 41008563›Full record

ArticleBiomolecules2025

Neuromuscular Defects in a

Kazuyoshi Itoh, Masaki Kurogochi, Tadashi Kaname, Jun-Ichi Furukawa, Shoko Nishihara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Disrupted O-GalNAc glycosylation as a mechanism and biomarker ofbioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kazuyoshi ItohGlycan and Life Systems Integration Center (GaLSIC), Soka University, Tokyo 192-8577, Japan.ORCID 0009-0004-5652-1355
Masaki KurogochiInstitute for Glyco-Core Research (iGCORE), Nagoya University, Nagoya 464-8601, Japan.
Tadashi KanameDepartment of Genome Medicine, National Center for Child Health and Development, Tokyo 157-8535, Japan.ORCID 0000-0003-0281-9610
Jun-Ichi FurukawaInstitute for Glyco-Core Research (iGCORE), Nagoya University, Nagoya 464-8601, Japan.ORCID 0000-0002-7284-2261
Shoko NishiharaGlycan and Life Systems Integration Center (GaLSIC), Soka University, Tokyo 192-8577, Japan.ORCID 0000-0002-1668-2603

Funding

Japan Agency for Medical Research and Development JP18ek0109288s1602Japan Agency for Medical Research and Development JP19ek0109288s0503Japan Agency for Medical Research and Development JP20ek0109301hJapan Agency for Medical Research and Development JP24ek0109760sJapan Agency for Medical Research and Development JP25ek0109815h0001Japan Agency for Medical Research and Development JP25ek0109815s0101Japan Society for the Promotion of Science JP23K14147
6 · The paper itself

Abstract

SLC35A2-CDG is a congenital disorder of glycosylation caused by mutations in the

Indexed as

Congenital Disorders of GlycosylationDrosophila ProteinsMonosaccharide Transport ProteinsNeuromuscular JunctionAnimalsDisease Models, AnimalDrosophilaDrosophila melanogasterGlycosylationHumansMutationUDP-Galactose TranslocatorsDrosophila ProteinsMonosaccharide Transport ProteinsUDP-Galactose Translocatorsbasement membraneDrosophilamucin-type O-glycanmuscleneuromuscular junctionSLC35A2-CDGT antigenUgalt

Identifiers

PMID41008563
PMCPMC12467441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.